avise patient portal

How can Avise help you?

Step 2: Your doctor orders the test. Chances are your provider knows about AVISE, but if they don't we will get them set-up quickly so they can send in your blood sample for testing. Step 3: Test results will be sent to your physician within 5 business days. Take the Next Step.

How do I get an Avise test?

AVISE Testing Advanced autoimmune lab tests to help support providers and patients throughout the patient care journey. Healthcare Providers Learn more about how CB-CAPS and AVISE testing can help your busy practice with the differential diagnosis, prognosis, monitoring, and therapeutic optimization of lupus and related connective tissue diseases.

What is the Avise AAV test?

AVISE testing provides state-of-the-art insight to aid physicians in the diagnosis, prognosis and monitoring of autoimmune conditions. This is a website for …

What is Avise CTD and how does it work?

Call AVISE at (888) 452-1522 to speak with a Patient Advocate Team member or Provider Relations.

How long does it take to get Avise results?

How long does it take to get results? AVISE CTD results are provided to the ordering physician within 5 business days from receipt of the sample.

What is Avise SLE prognostic?

AVISE® SLE Prognostic is a 10-marker panel developed to help assess a patient's potential risk for Thrombosis, Cardiovascular events, Lupus Nephritis and Neuropsychiatric Lupus.

How do I get my Avise test results?

How to get an AVISE Test:Step 1: Download the letter for your physician and bring it to your next appointment. Download Letter.Step 2: Your doctor orders the test. ... Step 3: Test results will be sent to your physician within 5 business days.

What is Avise panel?

AVISE® Lupus is a 10-marker diagnostic test containing Cell-Bound Complement Activation Products (CB-CAPs) and SLE associated markers designed to aid healthcare providers in a timely differential diagnosis of SLE.

Is Avise test accurate?

The AVISE test demonstrated high specificity and good sensitivity for predicting the development of SLE at 2 years and was the only biomarker in multivariate analysis to be associated with a diagnosis of SLE at 2 years. Interestingly, positive patients were also more likely to develop damage at baseline and 2 years.Mar 18, 2020

What does a positive Avise test mean?

A positive Avise Lupus test result aids in formulating a SLE diagnosis when diagnosis based on standard-of-care tests and clinical features may be challenging, and impacts patient management. Prospective studies will be performed to better evaluate the clinical utility of the test and of CB-CAPs as biomarkers of SLE.Oct 31, 2016

What does Avise lupus result equivocal mean?

AVISE® Lupus Result : Negative – Index: -5.0. A result is marked as equivocal when one or more critical values is close to a threshold that would significantly change the index value if the threshold was crossed.

What's the cause of lupus?

It's likely that lupus results from a combination of your genetics and your environment. It appears that people with an inherited predisposition for lupus may develop the disease when they come into contact with something in the environment that can trigger lupus. The cause of lupus in most cases, however, is unknown.Jan 27, 2021

What labs are abnormal with lupus?

Complete Blood Count (CBC) CBC provides information about the red blood cell (RBC), white blood cell (WBC), and platelet counts, and health of RBCs, all of which may be abnormal in lupus and may need treatment. Common issues are: Low RBC (hematocrit, hemoglobin). A normal hematocrit is 35-40%, hemoglobin 11.5-15.0.Jul 18, 2019

The Advanced Rheumatology Test for The Differential Diagnosis of SLE

AVISE CTD is an advanced autoimmune rheumatic disease test specifically designed to aid physicians in the differential diagnosis of systemic lupus erythematosus (SLE).

What assays are included in AVISE CTD

AVISE CTD contains the patented Lupus (SLE) biomarkers, CB-CAPs, which help to offer a 22% greater sensitivity compared to C3/C4, and 48% greater sensitivity compared to anti-dsDNA